feed,title,long_url,short_url
SeekingAlpha,Fulcrum Therapeutics: Value Loss On SCD Data Update Is Telling,https://seekingalpha.com/article/4520564,
SeekingAlpha,ASML: 50%+ Possible Downside Suggests It's Time To Sell,https://seekingalpha.com/article/4520562,
